Massachusetts’ top-tier biopharma cluster is weathering the storm wreaked by COVID-19 after a year in which it continued to attract jobs, especially R&D jobs,and venture capital (VC) investment—helping to keep the Bay State on top in two key measures of growth, according to a report issued this week by the statewide life sciences industry group.
The Bay State’s biopharma workforce grew 7.7% last year to a total 79,972 jobs, up from 74.256 in 2018, the Massachusetts Biotechnology Council (MassBio) reported in its 2020 Industry Snapshot, produced in partnership with Evaluate.